(Sharecast News) - AstraZeneca slumped on Monday after saying it was pausing plans to invest £200m at its Cambridge research site.
The pharmaceuticals giant confirmed the move after the close on Friday.

A spokesperson for the company said: "We constantly reassess the investment needs of our company and can confirm...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE